@juliaskripkaser
This is the most undervalued and most reasonably priced biotech analysis sub account out there, by far - if you want an excellent overview of any stock.
@frandanconia
Awesome weekly review Jason. Really enjoyed hearing the bearish side as it’s an essential part of due diligence. Really happy with your service.
@qfam7
These weekly reviews keep getting better. Without a doubt the most comprehensive coverage for biotech investors out there and luckily, it’s available to the general public. We all would be paying out the ear for banker coverage if it were not for your service.
Testimonials
Read testimonials from real Bio5C subscribers below:
@crosuel
Bio5C offers top notch research and invaluable into today’s biotech investing which would otherwise be unavailable for an average investor. The 5C models show investors which companies they should be investing in and which they should stay away from. My recent ADMA investment has netted me 45% profit and after years of losing money finally a service has arisen which gives common folk a way to better their lives. 2019 is shaping up to become my best year in Biotech thanks to Jason and Bio5C.
@philkalt
I’ve been investing in biotech stocks for nearly 20 years. Bio5C is easily the best biotech research service I’ve experienced. Jason has in-depth knowledge of the industry. His written reports are succinct but comprehensive. He provides the background info to show how he arrives at the 5C scores and PTs. The new weekly audio summaries are great. What’s not to like?
@sasbai12
Jason’s video this week: biotech red flags gave multiple data points and characteristics to be on the look out for. In a word: invaluable! My advice to anyone in biotechs? Keep learning, be open minded and have a trusted advisor.
@TheBio_Hunter
Great job on Bio5C. Friday video review was a great idea. Great job on your DD of the bio companies covered. Keep up the solid work.
Zack Haldeman
I’ve successfully traded in and out of several brand names based on Bio5C scores and recommendations, including VKTX in 2018 and ADMA in 2019. Jason’s service has also kept me from stepping on some landmines. The 5Cs help me monitor a company’s weakness and not just it’s strengths, recognizing that just one or two falling “C’s can sink a stock.
Mike (Individual Investor)
As can be seen by some of the posted testimony, Bio5C is a “must subscribe” for the sophisticated biotech investor. I’d like to attest that it is an invaluable tool for more casual followers of biotech as well. What I really enjoy about Bio5C is its ability to explain complex (at least to me) biotech concepts in a way that is easy to understand and relate to as an investment opportunity. Much like the popular professor who’s classes are always full and enthusiastically attended. Bio5C has made biotech investment and enjoyable activity for me. And the fact that I have made some nice returns as a result of investment ideas I got from the website makes it fun as well!
@nwnite
@Nap5C Great call on AGRX going into ADCOM for an up vote “I’m at 70%.” GOt in at .51 out at $1.70 Sweet!!!
@davidmabryPDX
Credit to @JNap5C ….. He called ADRX to perfection. ↑170% on the recommended trade. Bio5C service providing invaluable analysis and trade opps in biotech.
@geuceyhophead
Had some nice 30% profit trades this week with $ADMS & $ADMA based on some excellent research done by @JNap5C
@frandanconia
Awesome weekly review Jason. Really enjoyed hearing the bearish side as it’s an essential part of due diligence. Really happy with your service.
@nwnite
Great info on weekly update Jason. Research and analysis is very thorough. Will be adjusting trades based on date & unique insights. Thanks.